Dr. Denis Roy receives the 2021 Canadian Cardiovascular Society Research Achievement Award

October 21, 2021

Dr. Denis-Roy, a cardiologist emeritus at the Montreal Heart Institute (MHI), received the Canadian Cardiovascular Society (CCS) Research Achievement Award yesterday at the Canadian Cardiovascular Congress 2021. This prestigious award is given annually to an established investigator working on an aspect of cardiovascular research in Canada.

Canada’s Interventional Electrophysiology Pioneer

Read more

Dr. Jean-Claude Tardif Receives the Prestigious Margolese National Heart Disorders Prize

September 10, 2021

The Montreal Heart Institute (MHI) is proud to announce that Dr. Jean-Claude Tardif has been honoured with the 2021 Margolese National Heart Disorders Prize.

This prestigious distinction is awarded annually to a Canadian physician or scientist who makes outstanding contributions to heart disorders’ treatment, amelioration, or cure.

Read more

Health Canada approval of low-dose colchicine for cardiovascular disease based on the COLCOT study

August 27, 2021

MYINFLA™ 0.5 mg has been approved by Health Canada for the reduction of cardiovascular risk in patients with coronary disease. MONTREAL, August 27, 2021 – People with coronary disease now have a new treatment option to reduce the risk of cardiovascular events. Health Canada has issued a Notice of Compliance for the prescription drug MYINFLA™ (colchicine 0.5 mg tablets) based on the results of the Montreal Heart Institute (MHI)’s COLCOT clinical trial.

Read more